Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zoetis Inc Class A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 29,713,432
  • Shares Outstanding, K 489,110
  • Annual Sales, $ 4,888 M
  • Annual Income, $ 821,000 K
  • 36-Month Beta 1.02
  • Price/Sales 6.09
  • Price/Cash Flow 24.75
  • Price/Book 17.12

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.50 +2.10%
on 08/08/17
63.46 -4.27%
on 07/24/17
-1.71 (-2.74%)
since 07/18/17
3-Month
59.50 +2.10%
on 08/08/17
63.85 -4.85%
on 06/20/17
+0.84 (+1.40%)
since 05/18/17
52-Week
46.86 +29.64%
on 11/01/16
63.85 -4.85%
on 06/20/17
+8.46 (+16.18%)
since 08/18/16

Most Recent Stories

More News
Top Stock Reports for Cisco, Enterprise Products Partners & Prudential

Top Stock Reports for Cisco, Enterprise Products Partners & Prudential

UAL : 64.75 (+0.08%)
PRU : 101.95 (-0.69%)
CSCO : 30.37 (-2.16%)
ZTS : 60.75 (-0.25%)
EPD : 25.23 (+1.00%)
PSA : 196.29 (-0.73%)
Zoetis (ZTS) Beats on Q2 Earnings & Sales, Ups 2017 View

Zoetis (ZTS) reported impressive second-quarter results beating on both counts. The new launches and expansion of market for major products helped revenue growth.

SMMT : 12.21 (-3.86%)
ALNY : 81.42 (+1.42%)
ZTS : 60.75 (-0.25%)
ADRO : 10.75 (-3.15%)
Zoetis (ZTS) Q2 Earnings In-line, Sales Beat; 2017 View Up

Zoetis (ZTS) reported an in-line earnings per share while revenues beat estimates in the second quarter 2017.

ZTS : 60.75 (-0.25%)
Zoetis Announces Second Quarter 2017 Results

--Reports Adjusted Net Income of $261 Million, or Adjusted Diluted EPS of $0.53, for Second Quarter 2017

ZTS : 60.75 (-0.25%)
Perrigo Company (PRGO) Q2 Earnings: What's in the Cards?

Perrigo's (PRGO) Rx segment is likely to continue hurting the company's performance. However, product acquisitions and new product launches in the same might boost sales in the coming quarters.

ESPR : 44.74 (-0.53%)
ZTS : 60.75 (-0.25%)
TSRO : 113.86 (+4.41%)
PRGO : 77.27 (-0.54%)
Should You Buy Zoetis (ZTS) Ahead of Earnings?

Zoetis (ZTS) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.

ZTS : 60.75 (-0.25%)
Zoetis Appoints Dr. Linda Rhodes to Board of Directors

Zoetis Inc. (NYSE: ZTS) today announced the appointment of Dr. Linda Rhodes, an accomplished scientist, academic, veterinarian and business leader in animal health, to its Board of...

ZTS : 60.75 (-0.25%)
What's in Store for Puma (PBYI) this Earnings Season?

Recent approval of Puma's (PBYI) lead candidate, neratinib, by the FDA might offer a huge boost to the company in Q2, though no sales from the drug will be recorded during the same.

PBYI : 79.75 (-1.18%)
ZTS : 60.75 (-0.25%)
SNDX : 10.90 (-1.71%)
ARNA : 20.53 (-0.24%)
Is Zoetis (ZTS) Poised for a Beat This Earnings Season?

Zoetis, Inc. (ZTS) is expected to focus on performance of companion animal business during its second-quarter results.

BMRN : 80.92 (-0.07%)
ZTS : 60.75 (-0.25%)
IPXL : 18.45 (+2.79%)
TSRO : 113.86 (+4.41%)
What's in the Cards for Endo (ENDP) this Earnings Season?

Endo International plc (ENDP) remains focused on providing updates on its restructuring efforts across the Generics product as well as its manufacturing facility network in Q2.

ESPR : 44.74 (-0.53%)
ENDP : 8.72 (+1.04%)
ZTS : 60.75 (-0.25%)
TSRO : 113.86 (+4.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators are in flux.

See More

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Support & Resistance

2nd Resistance Point 61.40
1st Resistance Point 61.07
Last Price 60.75
1st Support Level 60.43
2nd Support Level 60.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.